James E. Fickenscher, Chief Financial Officer at AUXILIUM PHARMACEUTICALS INC (AUXL), sold 71,067 shares at $20.37 ($1.4M) on 2013-12-11, disclosed to the SEC on 2013-12-12.
Scheduled sale ($1.4M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ZYNE | SELL | 2022-07-20 | $7K | — | Filing → |
| ZYNE | BUY | 2018-08-07 | $102K | — | Filing → |
| ZYNE | BUY | 2017-05-16 | $103K | — | Filing → |